Related provisions for SUP 10C.15.2
Table: Explanation of the sections of the Act mentioned in SUP 10C.14.22R4
1Section |
Summary of relevant parts |
Other Handbook material |
Comments |
Section 63(2A) (Duty to notify regulator of grounds for withdrawal of approval) |
At least once a year, each firm must, in relation to every SMF manager for whom an approval has been given on the application of that firm: (a) consider whether there are any grounds on which the FCA could withdraw the approval; and (b) if the firm is of the opinion that there are such grounds, notify the FCA of those grounds. |
FIT sets out guidance on the factors a firm should take into account when assessing the fitness and propriety of an approved person. |
|
Section 64C of the Act (Requirement for 4authorised persons to notify regulator of disciplinary action) |
If: (a) a firm takes disciplinary action in relation to an SMF manager; and (b) the reason, or one of the reasons, for taking that action is a reason specified in SUP 15.11.6R; |
SUP 15.11 (Notification of COCON breaches and disciplinary action) |
An example of when a notification should be made using Form C rather than Form D is when a firm is required to notify the FCA under section 64C of the Act that it has dismissed an SMF manager. |
Table: FCA approved persons forms and other documents
1Form or other document |
Purpose |
Handbook requirement |
|
The6 relevant Form A |
Application to perform designated senior management functions6 |
||
Form B |
Notice to withdraw an application to perform controlled functions under the approved persons regime |
||
Notice to withdraw an application to vary an approval under the senior managers regime6 |
|||
Form C |
Notice of ceasing to perform controlled functions |
||
Form D |
Notification of changes in personal information or application details or functions |
||
Notification about fitness or of breach of conduct rules |
|||
Form E |
Internal transfer of an approved person |
||
Form I |
Application to vary a conditional approval 6 |
||
Form J |
Notification of significant change to a statement of responsibilities |
||
Relevant3statement of responsibilities 2 |
|||
4MiFID Article 4 SMR Information Form |
|||
4Annex III template |
https://www.fca.org.uk/publication/forms/mifid-changes-management-body-form.docx |
As required by the MiFID authorisation and management body change notification ITS6 |
|
Table: Method of submission
1Form or other document |
Firms that are not credit unions or consumer credit firms (SUP 10C.15.7D(1))7 |
Credit unions and consumer credit firms (SUP 10C.15.7D(2))7 |
The relevant Form A |
||
Form B |
||
Form C |
||
Form D |
||
Form E |
||
Form I |
||
Form J |
||
Relevant statement of responsibilities2 |
In accordance with the requirements for the form with which it is submitted |
In accordance with the requirements for the form with which it is submitted |
4MiFID Article 4 SMR Information Form |
Submit at the same time as Form A and/or E |
Not applicable |
Submit at the same time as Form A, C and/or E |
Not applicable |
The applicable due dates for submission referred to in 11SUP 16.12.4 R112 are set out in the table below. The due dates are the last day of the periods given in the table below following the relevant reporting frequency period set out in SUP 16.12.12 R, unless indicated otherwise.13
Daily |
Weekly |
Monthly18 |
Quarterly18 |
Half yearly18 |
Annual18 |
|
45COREP/FINREP |
Refer to EU CRR and applicable technical standards |
|||||
8 | 8 | |||||
Solvency statement |
3 months |
|||||
FSA001 |
30 business days (note 1) 45 business days (note 2) |
|||||
FSA002 |
30 business days (note 1) 45 business days (note 2) |
|||||
FSA003 |
30 business days (note 1) 45 business days (note 2) |
|||||
FSA004 |
30 business days (note 1) 45 business days (note 2) |
|||||
FSA005 |
30 business days (note 1) 45 business days (note 2) |
|||||
FSA006 |
||||||
FSA007 |
2 months |
|||||
FSA016 |
||||||
FSA018 |
||||||
FSA019 |
2 months |
|||||
FSA028 |
||||||
2FSA029 |
11 | |||||
2FSA030 |
11 | |||||
2FSA031 |
||||||
2FSA032 |
||||||
2FSA033 |
11 | |||||
2FSA034 |
11 | |||||
2FSA035 |
1143 | |||||
2FSA039 |
||||||
2FSA040 |
||||||
6FSA045 |
30 business days (note 1), 45 business days (note 2) |
|||||
6FSA046 |
20 business days (Note 1), 45 business days (Note 2)80 15 |
15 | ||||
FSA047 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3) |
|||
FSA048 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3) |
|||
FSA050 |
||||||
FSA051 |
||||||
FSA052 |
22.00 hours (London time) on the second business day immediately following the last day of the reporting period for the item in question |
|||||
FSA053 |
||||||
FSA054 |
||||||
FSA055 |
||||||
15FSA058 |
20 business days (Note 1), 45 business days (Note 2)80 38 |
|||||
38FIN067 |
45 | |||||
45FIN068 |
||||||
52FIN071 |
||||||
3Section A RMAR |
||||||
3Section B RMAR |
||||||
3Section C RMAR |
||||||
175050 | ||||||
3Section F RMAR |
||||||
46MLA-M |
||||||
Note 1 |
For unconsolidated and solo-consolidated reports. |
|||||
Note 2 |
For UK consolidation group reports. |
|||||
Note 3 |
It is one Month if the report relates to a non-UK DLG by modification. |
The applicable data items referred to in SUP 16.12.4 R are set out76 according to firm type76 in the table below:
Firms' prudential category and applicable data items (note 1) |
||||||||||
Firms other than BIPRU firms or IFPRU investment firms |
||||||||||
IPRU(INV) Chapter 3 |
IPRU(INV) Chapter 5 |
IPRU(INV) Chapter 9 |
IPRU(INV) Chapter 11 (collective portfolio management firms only) |
IPRU(INV) Chapter 13 |
38 | |||||
Solvency statement (Note 11) |
No standard format |
No standard format (Note 11) |
No standard format |
No standard format |
38 | |||||
Balance sheet |
FSA001/FINREP (Notes 2 and 34) |
FSA001 (Note 2) |
FSA029 |
FSA029 |
FSA029 |
FSA029 |
FSA02948 |
FSA029 (note 15) or Section A RMAR (note 15) |
38 | |
Income statement |
FSA002/FINREP (Notes 2 and 34) |
FSA002 (Note 2) |
FSA030 |
FSA030 |
FSA030 |
FSA030 |
FSA03048 |
FSA030 (note 15) or Section B RMAR (note 15) |
38 | |
Capital adequacy |
COREP (Note 34) |
FSA003 (Note 2) |
FSA033 |
FSA034 or FSA035 or FIN07152 (note 14) |
FSA031 |
FIN066 |
FIN06948 |
SectionD162 RMAR or FSA032 (note 15) 50 |
38 | |
Supplementary capital data for collective portfolio management investment firms |
FIN067 (Note 32) |
FIN068 (Note 32) |
||||||||
Credit risk |
COREP (Note 34) |
FSA004 (Notes 2, 3) |
||||||||
Market risk |
COREP (Note 34)50 |
FSA005 (Notes 2, 4) |
||||||||
Market risk - supplementary |
FSA006 (note 5) |
FSA006 (note 5) |
||||||||
Operational risk |
COREP (Note 34) |
|||||||||
Large exposures |
COREP (Note 34) |
|||||||||
Exposures between core UK group and non-core large exposures group |
FSA018 (note 12) |
|||||||||
Solo consolidation data |
FSA016 (note 20) |
FSA016 (Note 20) |
||||||||
Pillar 2 questionnaire |
FSA019 (note 8) |
FSA019 (Note 8) |
||||||||
Non-EEA subgroup |
COREP (Note 34) |
FSA028 (Note 9) |
||||||||
Threshold conditions |
Section F RMAR (note 15) |
|||||||||
Volumes and types of business (note 21) |
FSA038 |
FSA038 |
FSA038 |
FSA038 |
FSA038 |
FSA038 |
FSA038 |
38 | ||
Client money and client assets |
FSA039 |
FSA039 |
FSA039 |
FSA039 |
FSA039 |
FSA039 |
FSA03948 |
Section C RMAR (note 15) or FSA039 |
38 | |
38 | ||||||||||
IRB portfolio risk |
FSA045 (note 18) |
FSA045 (Note 18) |
||||||||
Securitisation: non-trading book |
COREP (Note 34) |
FSA046 (Note 19) |
||||||||
Daily Flows |
FSA047/COREP (Notes 23, 26, 28, 30 and 34) |
|||||||||
Enhanced Mismatch Report |
FSA048/COREP (Notes 23, 26, 28, 30 and 34) |
|||||||||
Liquidity Buffer Qualifying Securities |
FSA050/COREP (Notes 24, 27, 28, 30 and 34) |
|||||||||
Funding Concentration |
FSA051/COREP (Notes 24, 27, 28, 30 and 34) |
|||||||||
Pricing data |
FSA052/COREP (Notes 24, 28, 30, 31 and 34) |
|||||||||
Retail and corporate funding |
FSA053/COREP (Notes 24, 27, 28, 30 and 34) |
|||||||||
Currency Analysis |
FSA054/COREP (Notes 24, 27, 28, 30 and 34) |
|||||||||
Systems and Controls Questionnaire |
FSA055/COREP (Notes 25, 30 and 34) FSA055 (Notes 25 and 30) |
FSA055 (Notes 25 and 30) |
||||||||
Securitisation: trading book48 |
COREP (Note 34) |
FSA058 (Note 29) |
||||||||
Information on P2P agreements48 |
FIN07048 |
|||||||||
Note 1 |
All firms, except IFPRU investment firms in relation to data items reported under the EU CRR, when submitting the completed data item required, a firm must use the format of the data item set out in SUP 16 Annex 24 R. Guidance notes for completion of the data items are contained in SUP 16 Annex 25 G. |
|||||||||
Note 2 |
Firms that are members of a UK consolidation group are also required to submit this report on a UK consolidation group basis. |
|||||||||
Note 3 |
This applies to a firm that is required to submit data item FSA003 and at anytime within the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA004 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 77A in data item FSA003 is greater than £10 million, or its currency equivalent, at the relevant reporting date for the firm. |
|||||||||
Note 4 |
This applies to a firm that is required to submit data item FSA003 and at any time within the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA005 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 93A in data item FSA003 is greater than £50 million, or its currency equivalent, at the relevant reporting date for the firm. |
|||||||||
Note 5 |
Only applicable to firms with a VaR model permission. |
|||||||||
Note 6 |
[deleted] |
|||||||||
Note 7 |
[deleted] |
|||||||||
Note 8 |
Only applicable to IFPRU investment firms and BIPRU firms that:80 (a) are subject to consolidated supervision under BIPRU 8, except those that are either included within the consolidated supervision of a group that includes a UK credit institution, or that have been granted an investment firm consolidation waiver; or (b) have been granted an investment firm consolidation waiver; or (c) are not subject to consolidated supervision under BIPRU 8.80 An IFPRU investment firm and a BIPRU firm under (a) must complete the report on the basis of its UK consolidation group. An IFPRU investment firm and a BIPRU firm under (b) or (c) must complete the report on the basis of its solo position. |
|||||||||
Note 9 |
This will be applicable to firms that are members of a UK consolidation group on the reporting date. |
|||||||||
Note 10 |
[deleted]55 55 |
|||||||||
Note 11 |
Only applicable to a firm that is a sole trader or a partnership, when the report must be submitted by each partner. |
|||||||||
Note 12 |
Only applicable to a firm that has both a core UK group and a non-core large exposures group. |
|||||||||
Note 13 |
[deleted]55 55 |
|||||||||
Note 14 |
FSA034 must be completed by a firm not subject to the exemption in IPRU(INV) 5.4.2R74, unless it is a firm whose permitted business includes establishing, operating or winding up a personal pension scheme, in which case FIN071 must be completed76. FSA035 must be completed by a firm subject to the exemption in IPRU(INV) 5.4.2R7476. 7452 |
|||||||||
Note 15 |
FSA029, FSA030, FSA032 and FSA039 only apply to a firm subject to IPRU(INV) Chapter 13 which is an exempt CAD firm. Sections A, B, C, D162 and F RMAR only apply to a firm subject to IPRU(INV) Chapter 13 which is not an exempt CAD firm. 50 |
|||||||||
Note 16 |
[deleted] |
|||||||||
Note 17 |
[deleted] |
|||||||||
Note 18 |
Only applicable to firms that have an IRB permission. |
|||||||||
Note 19 |
Only applicable to firms that hold securitisation positions, or are the originator or sponsor of securitisations of non-trading book exposures. |
|||||||||
Note 20 |
Only applicable to a firm that has a solo consolidation waiver. |
|||||||||
Note 21 |
[deleted] |
|||||||||
Note 22 |
[deleted]72 |
|||||||||
Note 23 |
A firm must complete this item separately on each of the following bases (if applicable). (1) It must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it is a group liquidity reporting firm in a DLG by default and is a UK lead regulated firm, it must complete the item on the basis of that group. (3) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. (4) If it is a group liquidity reporting firm in a non-UK DLG by modification, it must complete the item on the basis of that group. |
|||||||||
Note 24 |
A firm must complete this item separately on each of the following bases that are applicable. (1) It must complete it on a solo basis unless it is a group liquidity reporting firm in a UK DLG by modification. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. |
|||||||||
Note 25 |
If it is a non-ILAS BIPRU firm, it must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. |
|||||||||
Note 26 |
(1) This item must be reported in the reporting currency. (2) If any data element is in a currency or currencies other than the reporting currency, all currencies (including the reporting currency) must be combined into a figure in the reporting currency. (3) In addition, all material currencies (which may include the reporting currency) must each be recorded separately (translated into the reporting currency). However if: (a) the reporting frequency is (whether under a rule or under a waiver) quarterly or less than quarterly; or (b) the only material currency is the reporting currency; (3) does not apply. (4) If there are more than three material currencies for this data item, (3) only applies to the three largest in amount. A firm must identify the largest in amount in accordance with the following procedure. (a) For each currency, take the largest of the asset or liability figure as referred to in the definition of material currency. (b) Take the three largest figures from the resulting list of amounts. (5) The date as at which the calculations for the purposes of the definition of material currency are carried out is the last day of the reporting period in question. (6) The reporting currency for this data item is whichever of the following currencies the firm chooses, namely USD (the United States Dollar), EUR (the euro), GBP (sterling), JPY (the Japanese Yen), CHF (the Swiss Franc), CAD (the Canadian Dollar) or SEK (the Swedish Krona). |
|||||||||
Note 27 |
Note 26 applies, except that paragraphs (3), (4), and (5) do not apply, meaning that material currencies must not be recorded separately. |
|||||||||
Note 28 |
Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements for the data item in question if the firm receives that intra-group liquidity modification or variation part of the way through such a period. If the change is that the firm does not have to report a particular data item or does not have to report it at a particular reporting level, the firm must nevertheless report that item or at that reporting level for any reporting period that has already begun. This paragraph is subject to anything that the intra-group liquidity modification says to the contrary. |
|||||||||
Note 29 |
Only applicable to firms that hold securitisation positions in the trading book and/or are the originator or sponsor of securitisations held in the trading book. |
|||||||||
Note 30 |
FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054 must be completed by an ILAS BIPRU firm. An ILAS BIPRU firm does not need to complete FSA055. A non-ILAS BIPRU firm must complete FSA055 and does not need to complete FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054. |
|||||||||
Note 31 |
This data item must be reported only in the currencies named in FSA052, so that liabilities in GBP are reported in GBP in rows 1 to 4, those in USD are reported in USD in rows 5 to 8, and those in Euro are reported in Euro in rows 9 to 12. Liabilities in other currencies are not to be reported. |
|||||||||
Note 32 |
Only applicable to firms that are collective portfolio management investment firms. |
|||||||||
Note 33 |
Only applicable to firms that have a managing investmentspermission. |
|||||||||
Note 34 |
Requirements under COREP and FINREP should be determined with reference to the EU CRR and applicable technical standards. |
The applicable reporting frequencies for data items referred to in SUP 16.12.15 R2 are set out in the table below according to firm type. Reporting frequencies are calculated from a firm'saccounting reference date, unless indicated otherwise.
Firms' prudential category |
||||||
IFPRU 125K firm and collective portfolio management investment firm |
Firmother than BIPRU firms or IFPRU investment firms |
|||||
COREP/FINREP |
Refer to EU CRR and applicable technical standards |
Refer to EU CRR and applicable technical standards |
||||
Solvency statement |
Annually |
Annually |
Annually |
Annually |
Annually |
|
FSA001 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA002 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA003 |
Half yearly |
Half yearly |
||||
FSA004 |
Half yearly |
Half yearly |
||||
FSA005 |
Half yearly |
Half yearly |
||||
FSA006 |
Quarterly |
Quarterly |
Quarterly |
Quarterly |
Quarterly |
|
FSA007 |
Annual (note 4) |
Annual (note 4) |
||||
FSA016 |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
||
FSA018 |
Quarterly |
Quarterly |
Quarterly |
|||
FSA019 |
Annually |
Annually |
Annually |
Annually |
Annually |
|
FSA028 |
Half yearly |
|||||
FSA029 |
Quarterly |
|||||
FSA030 |
Quarterly |
|||||
FSA031 |
Quarterly |
|||||
FSA032 |
Quarterly |
|||||
FSA033 |
Quarterly |
|||||
FSA034 |
Quarterly |
|||||
FSA035 |
Quarterly38 |
|||||
FSA038 |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
|
FSA039 |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
|
FSA045 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA046 |
Quarterly |
Quarterly |
||||
FSA047 |
Daily, weekly, monthly or quarterly (Notes 5, 6 and 8) |
Daily, weekly, monthly or quarterly (Notes 5, 7 and 8) |
||||
FSA048 |
Daily, weekly, monthly or quarterly (Notes 5, 6 and 8) |
Daily, weekly, monthly or quarterly (Notes 5, 7 and 8) |
||||
FSA050 |
Monthly (Note 5) |
Monthly (Note 5) |
||||
FSA051 |
Monthly (Note 5) |
Monthly (Note 5) |
||||
FSA052 |
Weekly or monthly (Notes 5 and 9) |
Weekly or monthly (Notes 5 and 10) |
||||
FSA053 |
Quarterly (Note 5) |
Quarterly (Note 5) |
||||
FSA054 |
Quarterly (Note 5) |
Quarterly (Note 5) |
||||
FSA055 |
Annually (Note 5) |
Annually (Note 5) |
Annually (Note 5) |
|||
FSA058 |
Quarterly |
Quarterly |
||||
FIN066 |
Quarterly |
|||||
FIN067 |
Quarterly (Note 5) |
|||||
FIN068 |
Half yearly |
|||||
48FIN069 |
48Quarterly |
|||||
48FIN070 |
48Quarterly |
|||||
52FIN071 |
Quarterly |
|||||
Section A RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section B RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section C RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section D1 62 RMAR 5050 |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section F RMAR |
Half yearly |
|||||
Note 1 |
[deleted] |
|||||
Note 2 |
Annual regulated business revenue up to and including £5 million. |
|||||
Note 3 |
Annual regulated business revenue over £5 million. |
|||||
Note 4 |
The reporting date for this data item is six months after a firm's most recent accounting reference date. |
|||||
Note 5 |
Reporting frequencies and reporting periods for this data item are calculated on a calendar year basis and not from a firm'saccounting reference date. In particular: (1) A week means the period beginning on Saturday and ending on Friday. (2) A month begins on the first day of the calendar month and ends on the last day of that month. (3) Quarters end on 31 March, 30 June, 30 September and 31 December. (4) Daily means each business day. All periods are calculated by reference to London time. Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements if the firm receives that intra-group liquidity modification or variation part of the way through such a period, unless the intra-group liquidity modification says otherwise. |
|||||
Note 6 |
If the report is on a solo basis the reporting frequency is as follows: (1) if the firm does not have an intra-group liquidity modification the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (2) if the firm is a group liquidity reporting firm in a non-UK DLG by modification (firm level) the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (3) the frequency is quarterly if the firm is a group liquidity reporting firm in a UK DLG by modification. |
|||||
Note 7 |
(1) If the report is by reference to the firm'sDLG by default the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (2) If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (3) If the report is by reference to the firm'snon-UK DLG by modification the reporting frequency is quarterly. |
|||||
Note 8 |
(1) If the reporting frequency is otherwise weekly, the item is to be reported on every business day if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (2) If the reporting frequency is otherwise monthly, the item is to be reported weekly if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (3) A firm must ensure that it would be able at all times to meet the requirements for daily or weekly reporting under paragraph (1) or (2) even if there is no firm-specific liquidity stress or market liquidity stress and none is expected. |
|||||
Note 9 |
If the report is on a solo basis the reporting frequency is as follows: (1) weekly if the firm is a standard frequency liquidity reporting firm; and (2) monthly if the firm is a low frequency liquidity reporting firm. |
|||||
Note 10 |
If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (1) weekly if the group liquidity standard frequency reporting conditions are met; (2) monthly if the group liquidity low frequency reporting conditions are met. |
The applicable due dates for submission referred to in SUP 16.12.4 R are set out in the table below. The due dates are the last day of the periods given in the table below following the relevant reporting frequency period set out in SUP 16.12.16 R, unless indicated otherwise.13
Daily |
Weekly |
Monthly 18 |
Quarterly 18 |
Half yearly 18 |
Annual 18 |
|
45COREP/FINREP |
Refer to EU CRR and applicable technical standards |
|||||
Solvency statement |
3 months |
|||||
FSA001 |
30 business days (note 2); 45 business days (note 3 ) |
|||||
FSA002 |
30 business days (note 2); 45 business days (note 3) |
|||||
FSA003 |
30 business days (note 2); 45 business days (note 3) |
|||||
FSA004 |
30 business days (note 2); 45 business days (note 3) |
|||||
FSA005 |
30 business days (note 2); 45 business days (note 3) |
|||||
FSA006 |
||||||
FSA007 |
2 months |
|||||
FSA016 |
||||||
FSA018 |
||||||
FSA019 |
2 months |
|||||
FSA028 |
||||||
FSA029 |
||||||
FSA030 |
||||||
FSA031 |
||||||
FSA032 |
||||||
FSA033 |
||||||
FSA034 |
||||||
FSA035 |
||||||
FSA038 |
||||||
FSA039 |
||||||
FSA045 |
30 business days (note 2); 45 business days (note 3) |
|||||
FSA046 |
20 business days (Note 2), 45 business days (Note 3)15 |
15 | ||||
FSA047 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 4) |
|||
FSA048 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 4) |
|||
FSA050 |
||||||
FSA051 |
||||||
FSA052 |
22.00 hours (London time) on the second business day immediately following the last day of the reporting period for the item in question |
|||||
FSA053 |
||||||
FSA054 |
||||||
FSA055 |
||||||
15FSA058 |
20 business days (Note 2), 45 business days (Note 3)38 |
|||||
38FIN066 |
||||||
38FIN067 |
30 days45 45 |
|||||
45FIN068 |
||||||
48FIN069 |
||||||
48FIN070 |
||||||
52FIN071 |
||||||
Section A RMAR |
||||||
Section B RMAR |
||||||
Section C RMAR |
||||||
Sections D1 and D2 RMAR80 50505062 |
||||||
Section F RMAR |
||||||
Note 1 |
[deleted] |
|||||
Note 2 |
For unconsolidated and solo-consolidated reports. |
|||||
Note 3 |
For UK consolidation group reports. |
|||||
Note 4 |
It is one Month if the report relates to a non-UK DLG by modification. |
2The applicable data items80 referred to in SUP 16.12.4 R are set out according to type of firm8 in the table below:
888Firms’76 prudential category and applicable data items76 (note 1) |
|||||
IPRU(INV) Chapter 3 |
IPRU(INV) Chapter 5 |
IPRU(INV) Chapter 9 |
IPRU(INV)Chapter 13 |
43 | |
Solvency statement (note 6)5 |
No standard format5 |
43 | |||
Balance sheet |
FSA029 11 |
FSA029 11 |
FSA029 |
FSA029 or Section A RMAR (note 7) 11 |
4311 |
Income statement |
FSA030 11 |
FSA030 11 |
FSA030 |
FSA030 or Section B RMAR (note 7) 11 |
4311 |
Capital adequacy |
FSA033 11 |
FSA031 |
FSA032 or Section D1 62RMAR (notes 5 and 7)20 5050 |
4311 | |
5Threshold conditions |
Section F RMAR (Note 7)24 |
||||
Client money and client assets |
FSA039 |
FSA039 |
FSA039 |
Section C RMAR (note 7) or 5FSA039 |
43 |
69Pillar 2 questionnaire |
FSA019 (note 8) |
||||
Note 1 |
When submitting the completed data item required, a firm must use the format of the data item set out in SUP 16 Annex 24. Guidance notes for completion of the data items are contained in SUP 16 Annex 25. |
||||
Note 2 |
[deleted]24 24 |
||||
Note 3 |
[deleted]11 11 |
||||
Note 4 |
FSA034 must be completed by a firm not subject to the exemption in IPRU(INV) 5.4.2R74, unless it is a firm whose permitted business includes establishing, operating or winding up a personal pension scheme, in which case FIN071 must be completed76. FSA035 must be completed by a firm subject to the exemption in IPRU(INV) 5.4.2R74, unless76 the firm is the depositary of a UCITS scheme in which case, FIN072 must be completed75.52 7569757469 |
||||
Note 5 |
FSA032 must be completed by a firm subject to IPRU(INV) Chapter 13 which is an exempt CAD firm. 50 |
||||
Note 6 |
Only applicable to a firm that is a partnership, when the report must be submitted by each partner. |
||||
5Note 7 |
FSA029, FSA030, FSA032 and FSA03924 only apply to a firm subject to IPRU(INV) Chapter 13 which is an exempt CAD firm. Sections A, B, C, D1, 62and F24 RMAR only apply 11 to a firm subject to IPRU(INV) Chapter 13 which is not an exempt CAD firm. 1124 |
||||
69Note 8 |
Only applicable to a firm that is the depositary of a UCITS scheme. |
2The applicable reporting frequencies for submission of data items referred to in SUP 16.12.4 R are set out in the table below. Reporting frequencies are calculated from a firm'saccounting reference date, unless indicated otherwise.
Solvency statement |
Annually |
69FSA019 |
Annually |
FSA029 |
Quarterly 8 |
FSA030 |
Quarterly 8 |
FSA031 |
Quarterly |
FSA032 |
Quarterly |
FSA033 |
Quarterly 8 |
FSA034 |
Quarterly 8 |
FSA035 |
Quarterly 843 |
FSA039 |
Half yearly11 |
52FIN071 |
Quarterly |
69FIN072 |
Quarterly |
5Section A RMAR |
Half yearly (note 2) Quarterly (note 3) |
5Section B RMAR |
Half yearly (note 2) Quarterly (note 3) |
5Section C RMAR |
Half yearly (note 2) Quarterly (note 3) |
Sections D1 and D2 RMAR80 50505062 |
Half yearly (note 2) Quarterly (note 3) |
5Section F RMAR |
Half yearly |
Note 1 |
[deleted]8 8 |
5Note 2 |
Annual regulated business revenue up to and including £5 million. |
5Note 3 |
5Annual regulated business revenue over £5 million. |
2The applicable due dates for submission referred to in SUP 16.12.4 R are set out in the table below. The due dates are the last day of the periods given in the table below following the relevant reporting frequency period set out in SUP 16.12.20 R.
Quarterly18 |
Half yearly18 |
Annual18 |
|
Solvency statement |
3 months |
||
69FSA019 |
2 months |
||
FSA029 |
11 | ||
FSA030 |
11 | ||
FSA031 |
|||
FSA032 |
|||
FSA033 |
11 | ||
FSA034 |
11 | ||
FSA035 |
1143 | ||
FSA039 |
|||
69 | |||
FSA040 |
15 business days 3 |
||
52FIN071 |
|||
75FIN072 |
|||
5Section A RMAR |
|||
5Section B RMAR |
|||
5Section C RMAR |
|||
Sections D1 and D2 RMAR80 4917495062 |
|||
5Section F RMAR |
2The applicable data items referred to in SUP 16.12.4 R are set out according to type of firm in the table below:
Firms' prudential category and applicable data item (note 1) |
||||||
Exempt CAD firmssubject toIPRU(INV)Chapter 13 |
Firms(other thanexempt CAD firms) subject toIPRU(INV)Chapter 13 |
Firmsthat are also in one or more ofRAGs1 to 6 and not subject toIPRU(INV)Chapter 13 |
||||
Solvency statement |
No standard format (note 11) |
|||||
Balance Sheet |
FSA001/FINREP (Notes 2 and 29) |
FSA001 (Note 2) |
FSA029 |
Section A RMAR |
||
Income Statement |
FSA002/FINREP (Notes 2 and 29) |
FSA002 (Note 2) |
FSA030 |
Section B RMAR |
||
Capital Adequacy |
COREP (Note 29) |
FSA003 (Note 2) |
FSA032 |
Section D1 62 RMAR (Note 23) 5050 |
||
Credit risk |
COREP (Note 29) |
FSA004 (Notes 2, 3) |
||||
Market risk |
COREP (Note 29) |
FSA005 (Notes 2, 4) |
||||
Market risk - supplementary |
FSA006 (note 5) |
FSA006 (Note 5) |
||||
Operational risk |
COREP (Note 29) |
|||||
Large exposures |
COREP (Note 29) |
|||||
Exposures between core UK group and non-core large exposures group |
FSA018 (note 12) |
|||||
Solo consolidation data |
FSA016 |
FSA016 |
||||
Pillar 2 questionnaire |
FSA019 (note 8) |
FSA019 (Note 8) |
||||
Non-EEA sub-group |
COREP (Note 29) |
FSA028 (Note 9) |
||||
Professional indemnity insurance (note 15) |
Section E RMAR |
Section E RMAR |
Section E RMAR |
Section E RMAR |
||
Threshold Conditions |
Section F RMAR |
Section F RMAR |
||||
Training and Competence |
Section G RMAR |
Section G RMAR |
Section G RMAR |
Section G RMAR |
Section G RMAR |
|
COBS data |
Section H RMAR |
Section H RMAR |
Section H RMAR |
Section H RMAR |
Section H RMAR |
|
Client money and client assets |
Section C RMAR |
Section C RMAR |
Section C RMAR |
Section C RMAR |
||
Fees and levies |
Section J RMAR |
Section J RMAR |
Section J RMAR |
Section J RMAR |
||
Section K RMAR (Note 26) |
Section K RMAR (Note 26) |
Section K RMAR (Note 26) |
Section K RMAR (Note 26) |
Section K RMAR (Note 26) |
||
IRB portfolio risk |
FSA045 (note 13) |
FSA045 (Note 13) |
||||
Securitisation: non-trading book |
COREP (note 29) |
FSA046 (Note 14) |
||||
Daily Flows |
FSA047/COREP (Notes 16, 19, 21, 24 and 29) |
|||||
Enhanced Mismatch Report |
FSA048/COREP (Notes 16, 19, 21, 24 and 29) |
|||||
Liquidity Buffer Qualifying Securities |
FSA050/COREP (Notes 17, 20, 21, 24 and 29) |
|||||
Funding Concentration |
FSA051/COREP (Notes 17, 20, 21, 24 and 29) |
|||||
Pricing data |
FSA052/COREP (Notes 17, 20, 21, 24 and 29) |
|||||
Retail and corporate funding |
FSA053/COREP (Notes 17, 20, 21, 24 and 29) |
|||||
Currency Analysis |
FSA054/COREP (Notes 17, 20, 21, 24 and 29) |
|||||
Systems and Controls Questionnaire |
FSA055/COREP (Notes 18, 24 and 29) |
FSA055 (Notes 18 and 24) |
||||
Securitisation: trading book |
COREP (Note 29) |
FSA058 (Note 22) |
||||
Supplementary capital data for collective portfolio management investment firms |
FIN067 (Note 28) |
FIN068 (Note 28) |
||||
Note 1 |
When submitting the completed data item required, a firm must use the format of the data item set out in SUP 16 Annex 24 R, or SUP 16 Annex 18A R in the case of the RMAR. Guidance notes for completion of the data items are contained in SUP 16 Annex 25 G, or SUP 16 Annex 18B G in the case of the RMAR. |
|||||
Note 2 |
Firms that are members of a UK consolidation group are also required to submit this report on a UK consolidation group basis. |
|||||
Note 3 |
This applies to a firm that is required to submit data item FSA003 and, at any time within80 the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA004 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 77A in data item FSA003 is greater than £10 million, or its currency equivalent, at the relevant reporting date for the firm. 5555 |
|||||
Note 4 |
This applies to a firm that is required to submit data item FSA003 and, at any time within the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA005 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 93A in data item FSA003 is greater than £50 million, or its currency equivalent, at the relevant reporting date for the firm. |
|||||
Note 5 |
Only applicable to firms with a VaR model permission. |
|||||
Note 6 |
[deleted] |
|||||
Note 7 |
[deleted] |
|||||
Note 8 |
Only applicable to IFPRU investment firms and BIPRU firms that: (a) are subject to consolidated supervision under BIPRU 8, except those that are either included within the consolidated supervision of a group that includes a UK credit institution, or that have been granted an investment firm consolidation waiver; or (b) have been granted an investment firm consolidation waiver; or (c) are not subject to consolidated supervision under BIPRU 8. An IFPRU investment firm and a BIPRU firm under (a) must complete the report on the basis of its UK consolidation group. An IFPRU investment firm and a BIPRU firm under (b) or (c) must complete the report on the basis of its solo position. |
|||||
Note 9 |
This will be applicable to firms that are members of a UK consolidation group on the reporting date. |
|||||
Note 10 |
[deleted]55 55 |
|||||
Note 11 |
Only applicable to a firm that is a sole trader or a partnership, when the report must be submitted by each partner. |
|||||
Note 12 |
Only applicable to a firm that has both a core UK group and a non-core large exposures group. |
|||||
Note 13 |
Only applicable to firms that have an IRB permission. |
|||||
Note 14 |
Only applicable to firms that hold securitisation positions, or are the originator or sponsor of securitisations of non-trading bookexposures. |
|||||
Note 15 |
This item only applies to firms that are subject to an FCA requirement to hold professional indemnity insurance and are not exempt CAD firms. |
|||||
Note 16 |
A firm must complete this item separately on each of the following bases (if applicable). (1) It must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it is a group liquidity reporting firm in a DLG by default and is a UK lead regulated firm, it must complete the item on the basis of that group. (3) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. (4) If it is a group liquidity reporting firm in a non-UK DLG by modification, it must complete the item on the basis of that group. |
|||||
Note 17 |
A firm must complete this item separately on each of the following bases that are applicable. (1) It must complete it on a solo basis unless it is a group liquidity reporting firm in a UK DLG by modification. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. |
|||||
Note 18 |
If it is a non-ILAS BIPRU firm, it must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. |
|||||
Note 19 |
(1) This item must be reported in the reporting currency. (2) If any data element is in a currency or currencies other than the reporting currency, all currencies (including the reporting currency) must be combined into a figure in the reporting currency. (3) In addition, all material currencies (which may include the reporting currency) must each be recorded separately (translated into the reporting currency). However if: (a) the reporting frequency is (whether under a rule or under a waiver) quarterly or less than quarterly; or (b) the only material currency is the reporting currency; (3) does not apply. (4) If there are more than three material currencies for this data item, (3) only applies to the three largest in amount. A firm must identify the largest in amount in accordance with the following procedure. (a) For each currency, take the largest of the asset or liability figure as referred to in the definition of material currency. (b) Take the three largest figures from the resulting list of amounts. (5) The date as at which the calculations for the purposes of the definition of material currency are carried out is the last day of the reporting period in question. (6) The reporting currency for this data item is whichever of the following currencies the firm chooses, namely USD (the United States Dollar), EUR (the euro), GBP (sterling), JPY (the Japanese Yen), CHF (the Swiss Franc), CAD (the Canadian Dollar) or SEK (the Swedish Krona). |
|||||
Note 20 |
Note 19 applies, except that paragraphs (3), (4) and (5) do not apply, meaning that material currencies must not be recorded separately. |
|||||
Note 21 |
Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements for the data item in question if the firm receives that intra-group liquidity modification or variation part of the way through such a period. If the change is that the firm does not have to report a particular data item or does not have to report it at a particular reporting level, the firm must nevertheless report that item or at that reporting level for any reporting period that has already begun. This paragraph is subject to anything that the intra-group liquidity modification says to the contrary. |
|||||
Note 22 |
Only applicable to firms that hold securitisation positions in the trading book and/ or are the originator or sponsor of securitisations held in the trading book. |
|||||
Note 23 |
Where a firm submits data items for both RAG 7 and RAG 9, the firm must complete Section D1.73 |
|||||
Note 24 |
FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054 must be completed by an ILAS BIPRU firm. An ILAS BIPRU firm does not need to complete FSA055. A non-ILAS BIPRU firm must complete FSA055 and does not need to complete FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054. |
|||||
Note 25 |
This data item must be reported only in the currencies named in FSA052, so that liabilities in GBP are reported in GBP in rows 1 to 4, those in USD are reported in USD in rows 5 to 8, and those in Euro are reported in Euro in rows 9 to 12. Liabilities in other currencies are not to be reported. |
|||||
Note 26 |
This item only applies to firms that provide advice on retail investment products and P2P agreements67. |
|||||
Note 27 |
[deleted]51 |
|||||
Note 28 |
Only applicable to firms that are collective portfolio management investment firms. |
|||||
Note 29 |
Requirements under COREP and FINREP should be determined with reference to the EU CRR and applicable technical standards. |
The applicable reporting frequencies for data items referred to in SUP 16.12.22A R are set out in the table below. Reporting frequencies are calculated from a firm'saccounting reference date, unless indicated otherwise.45
Frequency |
|||||
Unconsolidated BIPRU investment firm and IFPRU investment firm |
Solo consolidated BIPRU investment firm andIFPRU investment firm |
Annual regulated business revenue up to and including £5 million |
Annual regulated business revenue over £5 million |
||
COREP/FINREP |
Refer to EU CRR and applicable technical standards |
||||
Solvency statement |
Annually |
||||
FSA001 |
Quarterly or half yearly (Note 1) |
Quarterly or half yearly (Note 1) |
Half yearly |
||
FSA002 |
Quarterly or half yearly (Note 1) |
Quarterly or half yearly (Note 1) |
Half yearly |
||
FSA003 |
Monthly, quarterly or half yearly (Notes 2 and 11) |
Monthly, quarterly or half yearly (Notes 2 and 11) |
Half yearly |
||
FSA004 |
Quarterly or half yearly (Notes 1 and 11) |
Quarterly or half yearly (Notes 1 and 11) |
Half yearly |
||
FSA005 |
Quarterly or half yearly (Notes 1 and 11) |
Quarterly or half yearly (Notes 1 and 11) |
Half yearly |
||
FSA006 |
Quarterly |
Quarterly |
Quarterly |
||
FSA007 |
Annually |
||||
FSA016 |
Half yearly |
||||
FSA018 |
Quarterly |
Quarterly |
Quarterly |
||
FSA019 |
Annually |
Annually |
Annually |
||
FSA028 |
Half yearly (Note 11) |
Half yearly (Note 11) |
|||
FSA032 |
Quarterly |
Quarterly |
|||
FSA045 |
Quarterly or half yearly (Note 1) |
Quarterly or half yearly (Note 1) |
Half yearly |
||
FSA046 |
Quarterly |
Quarterly |
Quarterly |
||
FSA047 |
Daily, weekly, monthly or quarterly (Notes 4, 5 and 7) |
Daily, weekly, monthly or quarterly (Notes 4, 5, 7 and 10) |
Daily, weekly, monthly or quarterly (Notes 4, 6 and 7) |
||
FSA048 |
Daily, weekly, monthly or quarterly (Notes 4, 5 and 7) |
Daily, weekly, monthly or quarterly (Notes 4, 5, 7 and 10) |
Daily, weekly, monthly or quarterly (Notes 4, 6 and 7) |
||
FSA050 |
Monthly (Note 4) |
Monthly (Notes 4 and 10) |
Monthly (Note 4) |
||
FSA051 |
Monthly (Note 4) |
Monthly (Notes 4 and 10) |
Monthly (Note 4) |
||
FSA052 |
Weekly or monthly (Notes 4 and 8) |
Weekly or monthly (Notes 4, 8 and 10) |
Weekly or monthly (Notes 4 and 9) |
||
FSA053 |
Quarterly (Note 4) |
Quarterly (Notes 4 and 10) |
Quarterly (Note 4) |
||
FSA054 |
Quarterly (Note 4) |
Quarterly (Notes 4 and 10) |
Quarterly (Note 4) |
||
FSA055 |
Annually (Note 4) |
Annually (Notes 4 and 10) |
Annually (Note 4) |
||
FSA058 |
Quarterly (Note 11) |
Quarterly (Note 11) |
Quarterly |
||
FIN067 |
Quarterly (Note 4) |
Quarterly (Note 4) |
|||
FIN068 |
Half yearly |
Half yearly |
|||
Section A RMAR |
Half yearly |
Quarterly |
|||
Section B RMAR |
Half yearly |
Quarterly |
|||
Section C RMAR |
Half yearly |
Quarterly |
|||
Sections D1 and D2 RMAR80 505062 |
Half yearly |
Quarterly |
|||
Section E RMAR |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Quarterly |
Section F RMAR |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Section G RMAR |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Section H RMAR |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Section J RMAR |
Annually |
Annually |
Annually |
Annually |
Annually |
Section K RMAR |
Annually54 54 |
Annually54 54 |
Annually54 54 |
Annually54 54 |
Annually54 54 |
Note 1 |
IFPRU 730K firms and IFPRU 125K firms - quarterly; IFPRU 50K firms and BIPRU firms - half yearly. |
||||
Note 2 |
IFPRU 730K firms - monthly;80 IFPRU 125K firms - quarterly;80 IFPRU 50K firms and BIPRU firms - half yearly. |
||||
Note 3 |
The reporting date for this data item is six months after a firm's most recent accounting reference date. |
||||
Note 4 |
Reporting frequencies and reporting periods for this data item are calculated on a calendar year basis and not from a firm'saccounting reference date. In particular: (1) a week means the period beginning on Saturday and ending on Friday; (2) a month begins on the first day of the calendar month and ends on the last day of that month; (3) quarters end on 31 March, 30 June, 30 September and 31 December; (4) daily means each business day. All periods are calculated by reference to London time. Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements if the firm receives that intra-group liquidity modification or variation part of the way through such a period, unless the intra-group liquidity modification says otherwise. |
||||
Note 5 |
If the report is on a solo basis the reporting frequency is as follows: (1) if the firm does not have an intra-group liquidity modification the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (2) if the firm is a group liquidity reporting firm in a non-UK DLG by modification (firm level) the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (3) the frequency is quarterly if the firm is a group liquidity reporting firm in a UK DLG by modification. |
||||
Note 6 |
(1) If the report is by reference to the firm'sDLG by default the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (2) If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (3) If the report is by reference to the firm'snon-UK DLG by modification the reporting frequency is quarterly. |
||||
Note 7 |
(1) If the reporting frequency is otherwise weekly, the item is to be reported on every business day if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (2) If the reporting frequency is otherwise monthly, the item is to be reported weekly if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (3) A firm must ensure that it would be able at all times to meet the requirements for daily or weekly reporting under (1) or (2) even if there is no firm-specific liquidity stress or market liquidity stress and none is expected. |
||||
Note 8 |
If the report is on a solo basis the reporting frequency is as follows: (1) weekly if the firm is a standard frequency liquidity reporting firm; and (2) monthly if the firm is a low frequency liquidity reporting firm. |
||||
Note 9 |
If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (1) weekly if the group liquidity standard frequency reporting conditions are met; (2) monthly if the group liquidity low frequency reporting conditions are met. |
||||
Note 10 |
As specified in SUP 16.12.22A R, solo consolidation has no application to liquidity reporting. Therefore, it does not make any difference to the reporting of this item whether or not the firm is solo consolidated. |
||||
Note 11 |
Only applicable to firms that are not required to report a data item with a similar name and purpose under the EU CRR and applicable technical standards. |
45The applicable due dates for submission referred to in SUP 16.12.4 R are set out in the table below. The due dates are the last day of the periods given in the table below following the relevant reporting frequency period set out in SUP 16.12.23A R, unless indicated otherwise.
Daily |
Weekly |
Monthly |
Quarterly |
Half yearly |
Annual |
|
COREP/FINREP |
Refer to EU CRR and applicable technical standards |
|||||
Solvency statement |
3 months |
|||||
FSA001 |
30 business days (note 1); 45 business days (note 2) |
|||||
FSA002 |
30 business days (note 1); 45 business days (note 2) |
|||||
FSA003 |
||||||
FSA004 |
30 business days (note 1); 45 business days (note 2) |
|||||
FSA005 |
30 business days (note 1); 45 business days (note 2) |
|||||
FSA006 |
||||||
FSA016 |
||||||
FSA018 |
||||||
FSA019 |
2 months |
|||||
FSA028 |
||||||
FSA032 |
||||||
FSA045 |
30 business days (note 1), 45 business days (note 2) |
|||||
FSA046 |
||||||
FSA047 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3) |
|||
FSA048 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3) |
|||
FSA050 |
||||||
FSA051 |
||||||
FSA052 |
22.00 hours (London time) on the second business day immediately following the last day of the reporting period for the item in question |
|||||
FSA053 |
||||||
FSA054 |
||||||
FSA055 |
||||||
FSA058 |
20 business days (Note 1), 45 business days (Note 2) |
|||||
FIN067 |
30 days |
|||||
FIN068 |
30 days |
|||||
Section A RMAR |
||||||
Section B RMAR |
||||||
Section C RMAR |
||||||
Section D1 62 RMAR 5050 |
||||||
Section E RMAR |
||||||
Section F RMAR |
||||||
Section G RMAR |
||||||
Section H RMAR |
||||||
Section J RMAR |
30 business days |
|||||
Section K RMAR |
||||||
Note 1 |
For unconsolidated and solo consolidated reports.80 |
|||||
Note 2 |
For UK consolidation group reports.80 |
|||||
Note 3 |
It is one Month if the report relates to a non-UK DLG by modification. |
2The applicable data items referred to in SUP 16.12.4 R are set out according to type of firm in the table below:
Firmsother thanBIPRU firms or IFPRU investment firms |
||||||||
IPRU(INV)Chapter 3 |
IPRU(INV)Chapter 5 |
IPRU(INV)Chapter 9 |
IPRU(INV)Chapter 13 |
38 | ||||
Solvency statement (note 11) |
No standard format |
38 | ||||||
Balance sheet |
FSA001/FINREP (Notes 2 and 30) |
FSA001 (Note 2) |
FSA029 |
FSA029 |
FSA029 |
Section A RMAR (note 17) or FSA029 |
||
Income statement |
FSA002/FINREP (Notes 2 and 30) |
FSA002 (Note 2) |
FSA030 |
FSA030 |
FSA030 |
Section B RMAR (note 17) or FSA030 |
||
Capital adequacy |
COREP (Note 30) |
FSA003 (Note 2) |
FSA033 |
FSA034 or FSA035 or FIN07152 (note 14) |
FSA031 |
Section D1 62 RMAR (note 17) or FSA 032 (note 15) 50 |
38 | |
Credit risk |
COREP (Note 30 |
FSA004 (Notes 2, 3) |
||||||
Market risk |
COREP (Note 30) |
FSA005 (Notes 2, 4) |
||||||
Market risk - supplementary |
FSA006 (note 5) |
FSA006 (Note 5) |
||||||
Operational risk |
COREP (Note 30) |
|||||||
Large exposures |
COREP (Note 30) |
|||||||
UK Integrated group large exposures |
FSA018 (note 12) |
|||||||
Exposures between core UK group and non-core large exposures group |
FSA016 (note 20) |
|||||||
Solo consolidation data |
FSA016 (note 20) |
|||||||
Pillar 2 questionnaire |
FSA019 (note 8) |
FSA019 (Note 8) |
||||||
Non-EEA sub-group |
COREP (Note 30) |
FSA028 (Note 9) |
||||||
Threshold conditions |
Section F RMAR (note 17) |
|||||||
Client money and client assets |
FSA039 |
FSA039 |
FSA039 |
FSA039 |
FSA039 |
Section C RMAR (Note 13) or FSA039 |
38 | |
IRB portfolio risk |
FSA045 (note 18) |
FSA045 (Note 18) |
||||||
Securitisation: non-trading book |
COREP (Note 30) |
FSA046 (Note 19) |
||||||
Daily Flows |
FSA047/COREP (Notes 21, 24, 26, 28 and 30) |
|||||||
Enhanced Mismatch Report |
FSA048/COREP (Notes 21, 24, 26, 28 and 30) |
|||||||
Liquidity Buffer Qualifying Securities |
FSA050/COREP (Notes 22, 25, 26, 28 and 30) |
|||||||
Funding Concentration |
FSA051/COREP (Notes 22, 25, 26, 28 and 30) |
|||||||
Pricing data |
FSA052/COREP (Notes 22, 26, 28, 29 and 30) |
|||||||
Retail and corporate funding |
FSA053/COREP (Notes 22, 25, 26, 28 and 30) |
|||||||
Currency Analysis |
FSA054/COREP (Notes 22, 25, 26, 28 and 30) |
|||||||
Systems and Controls Questionnaire |
FSA055/COREP (Notes 23, 28 and 30) |
FSA055 (notes 23 and 28)45 |
||||||
Securitisation: trading book |
COREP (Note 30) |
FSA058 (Note 27) |
||||||
Note 1: |
When submitting the completed data item required, a firm must use the format of the data item set out in SUP 16 Annex 24 R. Guidance notes for completion of the data items are contained in SUP 16 Annex 25 G. |
|||||||
Note 2 |
Firms that are members of a UK consolidation group are also required to submit this report on a UK consolidation group basis. |
|||||||
Note 3 |
This applies to a firm that is required to submit data item FSA003 and, at any time within the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA004 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 77A in data item FSA003 is greater than £10 million, or its currency equivalent, at the relevant reporting date for the firm. |
|||||||
Note 4 |
This applies to a firm that is required to submit data item FSA003 and, at any time within the 12 months up to its latest accounting reference date ("the relevant period"), was reporting data item FSA005 ("Firm A") or not reporting this item ("Firm B"). In the case of Firm A it must report this data item if one or both of its last two submissions in the relevant period show that the threshold was exceeded. In the case of Firm B it must report this item if both the last two submissions in the relevant period show that the threshold has been exceeded. The threshold is exceeded where data element 93A in data item FSA003 is greater than £50 million, or its currency equivalent, at the relevant reporting date for the firm. |
|||||||
Note 5 |
Only applicable to firms with a VaR model permission. |
|||||||
Note 6 |
[deleted] |
|||||||
Note 7 |
[deleted] |
|||||||
Note 8 |
Only applicable to IFPRU investment firms and BIPRU firms that: (a) are subject to consolidated supervision under BIPRU 8, except those that are either included within the consolidated supervision of a group that includes a UK credit institution, or that have been granted an investment firm consolidation waiver; or (b) have been granted an investment firm consolidation waiver; or (c) are not subject to consolidated supervision under BIPRU 8. An IFPRU investment firm and BIPRU firm under (a) must complete the report on the basis of its UK consolidation group. An IFPRU investment firm and BIPRU firm under (b) or (c) must complete the report on the basis of its solo position. |
|||||||
Note 9 |
This will be applicable to firms that are members of a UK consolidation group on the reporting date. |
|||||||
Note 10 |
[deleted]55 55 |
|||||||
Note 11 |
Only applicable to a firm that is a sole trader or a partnership, when the report must be submitted by each partner. |
|||||||
Note 12 |
Only applicable to a firm that has both a core UK group and a non-core large exposures group. |
|||||||
Note 13 |
FSA039 must only be completed by a firm subject to IPRU(INV) Chapter 13 which is an exempt CAD firm. Section C RMAR must only be completed by a firm subject to IPRU(INV) Chapter 13 which is not an exempt CAD firm. |
|||||||
Note 14 |
FSA034 must be completed by a firm not subject to the exemption in IPRU(INV) 5.4.2R74, unless it is a firm whose permitted business includes establishing, operating or winding up a personal pension scheme, in which case FIN071 must be completed76. FSA035 must be completed by a firm subject to the exemption in IPRU(INV) 5.4.2R7476. 7452 |
|||||||
Note 15 |
FSA032 must be completed by a firm subject to IPRU(INV) Chapter 13 which is an exempt CAD firm. |
|||||||
Note 16 |
[deleted] |
|||||||
Note 17 |
This is only applicable to a firm subject to IPRU(INV) Chapter 13 that is not an exempt CAD firm. |
|||||||
Note 18 |
Only applicable to firms that have an IRB permission. |
|||||||
Note 19 |
Only applicable to firms that hold securitisation positions, or are the originator or sponsor of securitisations of non-trading bookexposures. |
|||||||
Note 20 |
Only applicable to a firm that has a solo consolidation waiver. |
|||||||
Note 21 |
A firm must complete this item separately on each of the following bases (if applicable). (1) It must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it a group liquidity reporting firm in a DLG by default and is a UK lead regulated firm, it must complete the item on the basis of that group. (3) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. (4) If it is a group liquidity reporting firm in a non-UK DLG by modification, it must complete the item on the basis of that group. |
|||||||
Note 22 |
A firm must complete this item separately on each of the following bases that are applicable. (1) It must complete it on a solo basis unless it is a group liquidity reporting firm in a UK DLG by modification. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. (2) If it is a group liquidity reporting firm in a UK DLG by modification, it must complete the item on the basis of that group. |
|||||||
Note 23 |
If it is a non-ILAS BIPRU firm, it must complete it on a solo basis. Therefore even if it has a solo consolidation waiver it must complete the item on an unconsolidated basis by reference to the firm alone. |
|||||||
Note 24 |
(1) This item must be reported in the reporting currency. (2) If any data element is in a currency or currencies other than the reporting currency, all currencies (including the reporting currency) must be combined into a figure in the reporting currency. (3) In addition, all material currencies (which may include the reporting currency) must each be recorded separately (translated into the reporting currency). However if: (a) the reporting frequency is (whether under a rule or under a waiver) quarterly or less than quarterly; or (b) the only material currency is the reporting currency; (3) does not apply. (4) If there are more than three material currencies for this data item, (3) only applies to the three largest in amount. A firm must identify the largest in amount in accordance with the following procedure. (a) For each currency, take the largest of the asset or liability figure as referred to in the definition of material currency. (b) Take the three largest figures from the resulting list of amounts. (5) The date as at which the calculations for the purposes of the definition of material currency are carried out is the last day of the reporting period in question. (6) The reporting currency for this data item is whichever of the following currencies the firm chooses, namely USD (the United States Dollar), EUR (the euro), GBP (sterling), JPY (the Japanese Yen), CHF (the Swiss Franc), CAD (the Canadian Dollar) or SEK (the Swedish Krona). |
|||||||
Note 25 |
Note 24 applies, except that paragraphs (3), (4) and (5) do not apply, meaning that material currencies must not be recorded separately. |
|||||||
Note 26 |
Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements for the data item in question if the firm receives that intra-group liquidity modification or variation part of the way through such a period. If the change is that the firm does not have to report a particular data item or does not have to report it at a particular reporting level, the firm must nevertheless report that item or at that reporting level for any reporting period that has already begun. This paragraph is subject to anything that the intra-group liquidity modification says to the contrary. |
|||||||
Note 27 |
Only applicable to firms that hold securitisation positions in the trading book and/or are the originator or sponsor of securitisations held in the trading book. |
|||||||
Note 28 |
FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054 must be completed by an ILAS BIPRU firm. An ILAS BIPRU firm does not need to complete FSA055. A non-ILAS BIPRU firm must complete FSA055 and does not need to complete FSA047, FSA048, FSA050, FSA051, FSA052, FSA053 and FSA054. |
|||||||
Note 29 |
This data item must be reported only in the currencies named in FSA052, so that liabilities in GBP are reported in GBP in rows 1 to 4, those in USD are reported in USD in rows 5 to 8, and those in Euro are reported in Euro in rows 9 to 12. Liabilities in other currencies are not to be reported. |
|||||||
Note 30 |
Requirements under COREP and FINREP should be determined with reference to the EU CRR and applicable technical standards. |
The applicable reporting frequencies for data items referred to in SUP 16.12.25A R are set out according to the type of firm2 in the table below. Reporting frequencies are calculated from a firm'saccounting reference date, unless indicated otherwise.
Firms' prudential category |
||||||
Firms other than BIPRU firms or IFPRU investment firms |
||||||
COREP/FINREP |
Refer to EU CRR and applicable technical standards |
Refer to EU CRR and applicable technical standards |
||||
Solvency statement |
Annually |
Annually |
Annually |
Annually |
Annually |
|
FSA001 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA002 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA003 |
Half yearly |
Half yearly |
||||
FSA004 |
Half yearly |
Half yearly |
||||
FSA005 |
Half yearly |
Half yearly |
||||
FSA006 |
Quarterly |
Quarterly |
Quarterly |
Quarterly |
||
FSA007 |
Annual (note 4) |
Annually (note 4) |
||||
FSA016 |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
||
FSA018 |
Quarterly |
Quarterly |
Quarterly |
|||
FSA019 |
Annually |
Annually |
Annually |
Annually |
Annually |
|
FSA028 |
Half yearly |
|||||
FSA029 |
Quarterly |
|||||
FSA030 |
Quarterly |
|||||
FSA031 |
Quarterly |
|||||
FSA032 |
Quarterly |
|||||
FSA033 |
Quarterly |
|||||
FSA034 |
Quarterly |
|||||
FSA035 |
Quarterly38 |
|||||
FSA039 |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
Half yearly |
|
FSA045 |
Quarterly |
Quarterly |
Half yearly |
Half yearly |
Half yearly |
|
FSA046 |
Quarterly |
|||||
FSA047 |
Daily, weekly, monthly or quarterly (Notes 5, 6 and 8) |
Daily, weekly, monthly or quarterly (Notes 5, 7 and 8) |
||||
FSA048 |
Daily, weekly, monthly or quarterly (Notes 5, 6 and 8) |
Daily, weekly, monthly or quarterly (Notes 5, 7 and 8) |
||||
FSA050 |
Monthly (Note 5) |
Monthly (Note 5) |
||||
FSA051 |
Monthly (Note 5) |
Monthly (Note 5) |
||||
FSA052 |
Weekly or monthly (Notes 5 and 9) |
Weekly or monthly (Notes 5 and 10) |
||||
FSA053 |
Quarterly (Note 5) |
Quarterly (Note 5) |
||||
FSA054 |
Quarterly (Note 5) |
Quarterly (Note 5) |
||||
FSA055 |
Annually (Note 5) |
Annually (Note 5) |
Annually (Note 5) |
|||
FSA058 |
[deleted] |
[deleted] |
[deleted] |
Quarterly |
Quarterly |
|
52FIN071 |
Quarterly |
|||||
Section A RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section B RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section C RMAR |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section D1 62 RMAR 5050 |
Half yearly (note 2) Quarterly (note 3) |
|||||
Section F RMAR |
Half yearly |
|||||
Note 1 |
[deleted] |
|||||
Note 2 |
Annual regulated business revenue up to and including £5 million. |
|||||
Note 3 |
Annual regulated business revenue over £5 million. |
|||||
Note 4 |
The reporting date for this data item is six months after a firm's most recent accounting reference date. |
|||||
Note 5 |
Reporting frequencies and reporting periods for this data item are calculated on a calendar year basis and not from a firm'saccounting reference date. In particular: (1) A week means the period beginning on Saturday and ending on Friday. (2) A month begins on the first day of the calendar month and ends on the last day of that month. (3) Quarters end on 31 March, 30 June, 30 September and 31 December. (4) Daily means each business day. All periods are calculated by reference to London time. Any changes to reporting requirements caused by a firm receiving an intra-group liquidity modification (or a variation to one) do not take effect until the first day of the next reporting period applicable under the changed reporting requirements if the firm receives that intra-group liquidity modification or variation part of the way through such a period, unless the intra-group liquidity modification says otherwise. |
|||||
Note 6 |
If the report is on a solo basis the reporting frequency is as follows: (1) if the firm does not have an intra-group liquidity modification the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (2) if the firm is a group liquidity reporting firm in a non-UK DLG by modification (firm level) the frequency is: (a) weekly if the firm is a standard frequency liquidity reporting firm; and (b) monthly if the firm is a low frequency liquidity reporting firm; (3) the frequency is quarterly if the firm is a group liquidity reporting firm in a UK DLG by modification. |
|||||
Note 7 |
(1) If the report is by reference to the firm'sDLG by default the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (2) If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (a) weekly if the group liquidity standard frequency reporting conditions are met; (b) monthly if the group liquidity low frequency reporting conditions are met. (3) If the report is by reference to the firm'snon-UK DLG by modification the reporting frequency is quarterly. |
|||||
Note 8 |
(1) If the reporting frequency is otherwise weekly, the item is to be reported on every business day if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (2) If the reporting frequency is otherwise monthly, the item is to be reported weekly if (and for as long as) there is a firm-specific liquidity stress or market liquidity stress in relation to the firm or group in question. (3) A firm must ensure that it would be able at all times to meet the requirements for daily or weekly reporting under paragraph (1) or (2) even if there is no firm-specific liquidity stress or market liquidity stress and none is expected. |
|||||
Note 9 |
If the report is on a solo basis the reporting frequency is as follows: (1) weekly if the firm is a standard frequency liquidity reporting firm; and (2) monthly if the firm is a low frequency liquidity reporting firm. |
|||||
Note 10 |
If the report is by reference to the firm'sUK DLG by modification the reporting frequency is: (1) weekly if the group liquidity standard frequency reporting conditions are met; (2) monthly if the group liquidity low frequency reporting conditions are met. |
The applicable due dates for submission referred to in SUP 16.12.4 R are set out in the table below. The due dates are the last day of the periods given in the table below following the relevant reporting frequency period set out in SUP 16.12.26 R, unless indicated otherwise13.
Daily |
Weekly |
Monthly 18 |
Quarterly 18 |
Half yearly 18 |
Annual 18 |
|
45COREP/FINREP |
Refer to EU CRR and applicable technical standards |
|||||
Annual reconciliation |
||||||
Solvency statement |
3 months |
|||||
FSA001 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA002 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA003 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA004 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA005 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA006 |
30 business days (note 1); 4580business days (note 2) |
|||||
FSA007 |
2 months |
|||||
FSA016 |
||||||
FSA018 |
||||||
FSA019 |
2 months |
|||||
FSA028 |
||||||
FSA029 |
||||||
FSA030 |
||||||
FSA031 |
||||||
FSA032 |
||||||
FSA033 |
||||||
FSA034 |
||||||
FSA035 |
||||||
FSA039 |
||||||
FSA040 |
||||||
FSA045 |
30 business days (note 1); 45 business days (note 2) |
|||||
FSA046 |
20 business days80 (Note 1); 45 business days80 (Note 2) 15 |
15 | ||||
FSA04713 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3)24 24 |
|||
FSA048 |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
22.00 hours (London time) on the business day immediately following the last day of the reporting period for the item in question |
15 business days or one Month (Note 3)24 24 |
|||
FSA050 |
||||||
FSA051 |
||||||
FSA052 |
22.00 hours (London time) on the second business day immediately following the last day of the reporting period for the item in question |
|||||
FSA053 |
||||||
FSA054 |
||||||
FSA055 |
||||||
15FSA058 |
20 business days (Note 1), 45 business days (Note 2) |
|||||
52FIN071 |
||||||
Section A RMAR |
||||||
Section B RMAR |
||||||
Section C RMAR |
||||||
Section D1 62RMAR 50175050 |
||||||
Section F RMAR |
||||||
Note 1 |
For unconsolidated and solo consolidated reports. |
|||||
Note 2 |
For UK consolidation group reports.80 |
|||||
Note 3 |
It is one Month if the report relates to a non-UK DLG by modification. |
Financial reports from a member of a financial conglomerate (see SUP 16.12.32 R)
Content of Report |
Form (Note 1) |
Frequency |
Due Date |
Calculation of supplementary capital adequacy requirements in accordance with one of the three42 technical calculation methods 42 |
Note 2 |
Note 5 Yearly42 |
Note 5 |
Identification of significant risk concentration levels |
Note 3 |
Yearly |
4 months after year end |
Identification of significant intra-group transactions |
Note 4 |
Yearly |
4 months after year end |
Report on compliance with GENPRU 3.1.35 R where it applies 11 |
Note 6 |
Note 5 |
Note 5 |
Note 1 |
When giving the report required, a firm must use the form indicated, if any. |
||
Note 2 |
In respect of FCA-authorised persons, if39 Part 1 of GENPRU3 Annex 1 (method80 1), or Part 2 of GENPRU 3 Annex 1 (method 2), or Part 3 of GENPRU 3 Annex 1 (method 3) applies, there is no specific form. Adequate information must be provided, specifying the calculation method used42 and each financial conglomerate for which the FCA68 is the co-ordinator must discuss with the FCA68 the form which this reporting will take and the extent to which verification by an auditor will be required.42 1168429696969642 |
||
42 | |||
42 | |||
7942424242 | |||
Note 3 |
Rather than specifying a standard format for each financial conglomerate to use, each financial conglomerate for which the FCA68 is the co-ordinator must discuss with the FCA68 the form of the information to be reported. This should mean that usual information management systems of the financial conglomerate can be used to the extent possible to generate and analyse the information required. When reviewing the risk concentration levels, the FCA68 will in particular monitor the possible risk of contagion in the financial conglomerate, the risk of a conflict of interests, the risk of circumvention of sectoral rules68, and the level or volume of risks. 969696969696 |
||
Note 4 |
For the purposes of this reporting requirement, an intra-group transaction will be presumed to be significant if its amount exceeds 5% of the total amount of capital adequacy requirements at the level of the financial conglomerate. Rather than specifying a standard format for each financial conglomerate to use, each financial conglomerate for which the FCA68 is the co-ordinator must11 discuss with the FCA68 the form of the information to be reported. This should mean that the68 usual information management systems of the financial conglomerate can be used to the extent possible to generate and analyse the information required. When reviewing the intra-group transactions, the FCA68 will in particular monitor the possible risk of contagion in the financial conglomerate, the risk of a conflict of interest11, the risk of circumvention of sectoral rules, and the level or volume of risks. 96961196969696 |
||
Note 5 |
The frequency and due date will be as follows: (1) banking and investment services conglomerate; frequency is yearly80 with due date 45 business days after period end;42 and68 (2) insurance conglomerate: frequency is yearly with due date four months after period end for the capital adequacy return and three months after period end for the report on compliance with GENPRU 3.1.35 R where it applies. 116811684242 |
||
Note 6 |
Adequate information must be added as a separate item to the relevant form for sectoral reporting. |
Outsourcing arrangements
1Outsourcing arrangements |
Explanation |
Submitting form |
The FCA will consider A to have taken reasonable care if it enters into a contract with B under which B is responsible for ensuring that the relevant FCA-designated senior management functions are performed by FCA-approved SMF managers, and that it is reasonable for A to rely on this. |
Firm B submits FCA-approved persons forms on behalf of firm A. |
|
Outsourcing by A to B (both being a member of the same United Kingdomgroup and each having its registered office in the United Kingdom) |
See SUP 10C.3.9G |
Either A or B may submit FCA-approved persons forms on behalf of firms in the group (see SUP 15.7.8G). |
(i) A to B, where B: (a) is not an authorised person; and (b) is not part of the same group as A; or (ii) A to B, where A is a branch of an overseas firm in the United Kingdom, and B is an overseasundertaking of the same group; or (iii) A to B, where A is a UK authorised subsidiary of an overseas firm and B is an overseasundertaking of the same group. |
Responsibility for (as opposed to the performance of) any activity outsourced to B will remain with A. See SYSC 8. |
A ensures that an individual approved by the FCA or the PRA to perform a designated senior management function has responsibility for the outsourcedarrangement and A submits a form in relation to that individual. |
Table: Examples5 of how the requirements for submitting statements of responsibilities work
1Example |
Comments |
(1) A firm applies for approval for A to perform the executive director function5 and the money laundering reporting function5. |
There should be a single statement of responsibilities document that covers the two functions. The combined document should be included with the application for approval. |
(2) Firm X applies for approval for A to perform the executive director function5. Firm Y applies for approval for A to perform the money laundering reporting function. Both firms are SMCR firms5. |
There should be separate statements of responsibilities for each firm. This is the case even if Firm X and Firm Y are in the same group. |
(3) A firm applies for approval for A to perform an FCA-designated senior management function and a PRA-designated senior management function. The arrangements in SUP 10C.9 for FCA functions to be absorbed into PRA ones do not apply and so there are separate applications to the FCA and PRA. The firm is a PRA-authorised person.6 |
The single statement of responsibilities document should cover both the FCA and the PRA functions. |
(4) A has approval to perform the executive director function5. Later, A is to be appointed to perform the money laundering reporting function5 for the same firm. This will also result in substantial changes to A’s duties as an executive director. |
The firm should not use Form J to notify the changes to A’s duties as an executive director. The firm should submit a revised single statement of responsibilities document along with the application to perform the money laundering reporting function5. The single statement of responsibilities document should cover both functions. The part relating to A’s duties as an executive director should be updated. |
(5) A has approval to perform the executive director function5. Later, A is to be appointed to perform the PRA's chief risk officer designated senior management function for the same firm. This will also result in substantial changes to A’s duties as an executive director. The firm is a PRA-authorised person.6 |
The firm should not use Form J to notify the changes to A’s duties as an executive director. The firm should submit a revised single statement of responsibilities document along with the application to perform the PRA function. The firm should not submit the revised single statement of responsibilities document separately to the FCA. Instead, it should include it as part of the application to the PRA. The single statement of responsibilities document should cover both the FCA and the PRA functions. The part relating to A’s duties as an executive director should be updated. |
(6) A has approval to perform the money laundering reporting function5. The approval to perform the money laundering reporting function5 is subject to a condition. The firm is applying to vary that condition. |
The firm should include a revised statement of responsibilities with the application. The firm should not use Form J. It should submit a revised statement of responsibilities along with the application to vary the approval. |
(7) A has approval to perform the executive director function5 and the money laundering reporting function5 for the same firm. The approval to perform the money laundering reporting function5 is subject to a condition. The firm is applying to vary that condition. As part of the same arrangements, there are to be substantial changes to A’s job as an executive director. |
The firm should not use Form J to notify the changes to A’s duties as an executive director. The firm should submit a revised single statement of responsibilities document along with the application to vary the approval for the money laundering reporting function5. The single statement of responsibilities document should be updated and should cover both functions. |
(8) A has approval to perform the executive director function5 and the PRA's chief risk officer designated senior management function for the same firm. The arrangements in SUP 10C.9 for FCA functions to be absorbed into PRA ones do not apply and so there are separate FCA and PRA approvals. The approval to perform the PRA's chief risk officer designated senior management function is subject to a condition. The firm is applying to vary that condition. As part of the same arrangements, there are to be substantial changes to A’s job as an executive director. The firm is a PRA-authorised person.6 |
The firm should not use Form J to notify the changes to A’s duties as an executive director. The firm should submit a revised single statement of responsibilities document along with the application to vary the PRA function. The firm should not submit the revised document separately to the FCA. Instead it should include it as part of the application to the PRA. The single statement of responsibilities document should cover both the FCA and the PRA functions and should be updated. |
(9) A has approval to perform the executive director function5 and the money laundering reporting function5 for the same firm. Sometime later, A is to give up the money laundering reporting function5 and take up the PRA's chief risk officer designated senior management function. This will involve major changes to A’s role as executive director. The firm is a PRA-authorised person.6 |
The answer to example (5) applies. The application to the PRA to perform the PRA function should be accompanied by a single document that: (1) contains the statement of responsibilities for the new function; (2) contains the revised statement of responsibilities for the executive director function5; and (3) reflects the fact that A is no longer performing the money laundering reporting function5. |
(10) A firm has approval for A to perform the executive director function5 and the money laundering reporting function5. A then ceases to perform the money laundering reporting function5 but continues to perform the executive director function.5 |
The firm must submit: (a) Form C for the money laundering reporting function5; (b) Form J; and (c) a single updated statement of responsibilities document that covers the executive director function and reflects the fact that A is no longer performing the money laundering reporting function5. |
(11) A has approval to perform the executive director function5 and the PRA's chief risk officer designated senior management function for the same firm. Later, A gives up his role as chief risk officer. The firm is a PRA-authorised person.6 |
The firm must submit: (a) Form C for the PRA function; (b) Form J; and (c) a single updated statement of responsibilities document that covers the executive director function5. The firm should not submit the revised single statement of responsibilities document separately to the FCA. Instead, it should include it as part of the notification to the PRA. |
(12) A has approval to perform the executive director function5. Later, A is to be appointed to perform the money laundering reporting function5 for the same firm. The application is rejected. |
The single statement of responsibilities document submitted as part of the application will no longer be correct as it reflects the proposed new approval. If the only changes to the single document in the version sent with the application are ones5 clearly and exclusively tied to the new function, the firm will not need to amend the document as the changes will automatically fall away. In any other case (for instance if the application is approved conditionally), it is likely that the firm will need to update it using Form J. In any case, the FCA may contact the firm to agree a revised single statement of responsibilities document. |
(13) A has approval to perform the money laundering reporting function5. Later, A is to be appointed as an executive director5 for the same firm. This will not result in any significant5 changes to A’s duties in the money laundering reporting function5. However, there have been some insignificant changes to A’s role in the money laundering reporting function5 since the firm submitted the most recent single statement of responsibilities document. The changes are not connected to A’s appointment as executive director5. |
The answer for example (4) applies. The single statement of responsibilities document should be updated to cover the changes to A’s duties in the money laundering role as well as covering A’s appointment to perform the executive director function. It does not matter that the changes to A’s money laundering role5 are not significant. |
(14) A has approval to perform the executive director function5. Later, A’s business unit grows in size and so the firm needs to apply for A to be approved to perform the PRA's Head of Key Business Area designated senior management function. However, A’s responsibilities do not change. The firm is a PRA-authorised person.6 |
The firm should submit a revised single statement of responsibilities document along with the application to perform the PRA function. The firm should submit a single statement of responsibilities document that covers both the FCA and the PRA functions. It should not submit the revised single statement of responsibilities document separately to the FCA. Instead, it should include it as part of the application to the PRA. |
2(15) Firm X has a branch in the United Kingdom. Firm Y is a UK authorised subsidiary3 of firm X. Firm X is an overseas SMCR firm that is not an EEA SMCR firm5 and firm3 Y is a UK SMCR firm5. Both firms apply for approval for the same individual (P) to perform the executive director function5. 3 |
There should be separate statement of responsibilities for P for each firm. |
Note:5 The single statement of responsibilities document means the single document described in SUP 10C.11.13D.5 |